A Survey of NOMA-Aided Cell-Free Massive MIMO Systems
Electronics · 2024-01-04 · 13 (1) · 231
DOI: 10.3390/electronics13010231 ↗At a glance
Journal article in Electronics, published online on 2024-01-04. Written by Antonio Apiyo and 1 co-authors. Cited 24 times so far (Crossref); 137 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
The Internet of Everything is leading to an increasingly connected intelligent digital world. Envisaged sixth-generation wireless networks require new solutions and technologies due to stringent network requirements. The benefits of cell-free massive MIMO (CF-mMIMO) and non-orthogonal multiple access (NOMA) have brought substantial attention to these approaches as potential technologies for future networks. In CF-mMIMO, numerous distributed access points are linked to a central processing unit, which allocates the same time-frequency resources to a smaller group of users. On the other hand, NOMA can support more users than its orthogonal counterparts by utilizing non-orthogonal resource allocation. This paper provides a comprehensive review and survey of NOMA-aided CF-mMIMO (CF-mMIMO-NOMA). Specifically, we present a comprehensive review of massive MIMO, CF-mMIMO, and NOMA. We then present a state-of-the-art research review of CF-mMIMO-NOMA. Finally, we discuss the challenges and potential of combining CF-mMIMO-NOMA with other enabling technologies to enhance performance.
Cite
APA
Apiyo, A., & Izydorczyk, J. (2024). A Survey of NOMA-Aided Cell-Free Massive MIMO Systems. Electronics, 13(1), 231. https://doi.org/10.3390/electronics13010231
Vancouver
Apiyo A, Izydorczyk J. A Survey of NOMA-Aided Cell-Free Massive MIMO Systems. Electronics. 2024;13(1):231. doi:10.3390/electronics13010231
BibTeX
@article{Apiyo2024,
author = {Apiyo, Antonio and Izydorczyk, Jacek},
title = {A Survey of NOMA-Aided Cell-Free Massive MIMO Systems},
journal = {Electronics},
year = {2024},
volume = {13},
number = {1},
pages = {231},
doi = {10.3390/electronics13010231}
}
EUVIMED